GlobeNewswire Inc | Apr 26, 2021 04:05PM EDT

April 26, 2021

SILVER SPRING, Md., April 26, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the Company will participate in the upcoming Truist Securities Life Sciences Summit.

Date: Wednesday, May 5, 2021Format: Fireside chat at 11:20 a.m. ETA link to the fireside chat presentation will be available on the Investors section of the Companys website at www.Aziyo.com.

About Aziyo Biologics Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties. For more information, visit www.Aziyo.com.

Media:Courtney GuyerAziyo Biologics, Inc.PR@aziyo.com

Investors:Leigh Salvo Gilmartin Groupinvestors@aziyo.com